Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer L Harris

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
The Biochemical Journal|July 5, 2007
Secreted PCSK9 promotes LDL receptor degradation independently of proteolytic activityJun Li, Christine Tumanut, Julie-Ann Gavigan, et al.
The Biochemical Journal|July 17, 2010
Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domainChristian C Lee, Yong Jia, Nanxin Li, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Discovery of inhibitors of the channel-activating protease prostasin (CAP1/PRSS8) utilizing structure-based designDavid C Tully, Agnès Vidal, Arnab K Chatterjee, et al.
ACS Medicinal Chemistry Letters|July 21, 2016
Discovery of Pyridinyl Acetamide Derivatives as Potent, Selective, and Orally Bioavailable Porcupine InhibitorsDai Cheng, Jun Liu, Dong Han, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 9, 2013
Enhanced proteolytic clearance of plasma Aβ by peripherally administered neprilysin does not result in reduced levels of brain Aβ in miceJohn R Walker, Reynand Pacoma, James Watson, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|April 28, 2016
In vivo Wnt pathway inhibition of human squamous cell carcinoma growth and metastasis in the chick chorioallantoic modelShannon F Rudy, J Chad Brenner, Jennifer L Harris, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2006
Arylaminoethyl carbamates as a novel series of potent and selective cathepsin S inhibitorsDavid C Tully, Hong Liu, Arnab K Chatterjee, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2006
Synthesis and evaluation of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 3: heterocyclic P3David C Tully, Hong Liu, Phil B Alper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2005
Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomasHoward A Burris, Herbert I Hurwitz, E Claire Dees, et al.
Annals of the Rheumatic Diseases|February 4, 2017
Pharmacological inhibition of porcupine induces regression of experimental skin fibrosis by targeting Wnt signallingChih-Wei Chen, Christian Beyer, Jun Liu, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
The Biochemical Journal|July 5, 2007
Secreted PCSK9 promotes LDL receptor degradation independently of proteolytic activityJun Li, Christine Tumanut, Julie-Ann Gavigan, et al.
The Biochemical Journal|July 17, 2010
Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domainChristian C Lee, Yong Jia, Nanxin Li, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Discovery of inhibitors of the channel-activating protease prostasin (CAP1/PRSS8) utilizing structure-based designDavid C Tully, Agnès Vidal, Arnab K Chatterjee, et al.
ACS Medicinal Chemistry Letters|July 21, 2016
Discovery of Pyridinyl Acetamide Derivatives as Potent, Selective, and Orally Bioavailable Porcupine InhibitorsDai Cheng, Jun Liu, Dong Han, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 9, 2013
Enhanced proteolytic clearance of plasma Aβ by peripherally administered neprilysin does not result in reduced levels of brain Aβ in miceJohn R Walker, Reynand Pacoma, James Watson, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|April 28, 2016
In vivo Wnt pathway inhibition of human squamous cell carcinoma growth and metastasis in the chick chorioallantoic modelShannon F Rudy, J Chad Brenner, Jennifer L Harris, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2006
Arylaminoethyl carbamates as a novel series of potent and selective cathepsin S inhibitorsDavid C Tully, Hong Liu, Arnab K Chatterjee, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2006
Synthesis and evaluation of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 3: heterocyclic P3David C Tully, Hong Liu, Phil B Alper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2005
Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomasHoward A Burris, Herbert I Hurwitz, E Claire Dees, et al.
Annals of the Rheumatic Diseases|February 4, 2017
Pharmacological inhibition of porcupine induces regression of experimental skin fibrosis by targeting Wnt signallingChih-Wei Chen, Christian Beyer, Jun Liu, et al.
Pageof 15